AbCellera to Present Virtually at the 11th Annual SVB Leerink Global Healthcare Conference on February 17, 2022
AbCellera (Nasdaq: ABCL) will present virtually at the 11th Annual SVB Leerink Global Healthcare Conference on February 17, 2022, at 12:40 p.m. PT. Investors and interested parties can access the live audio webcast on AbCellera's Investor Relations website, with a replay available afterward. AbCellera is a tech company specializing in analyzing immune systems to discover antibodies for drug development, partnering with pharmaceutical and biotechnology firms to streamline processes and address challenges in drug development.
- None.
- None.
A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be available through the same link following the presentation.
About
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.
Source:
View source version on businesswire.com: https://www.businesswire.com/news/home/20220211005577/en/
Media:
Business Development:
Investor Relations:
Source:
FAQ
When will AbCellera present at the SVB Leerink Global Healthcare Conference?
How can I access the AbCellera presentation?
What does AbCellera specialize in?
What is the stock symbol for AbCellera?
What kind of companies does AbCellera partner with?
